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ABSTRACT
Background. Recognized disparities in quality of end-of-life
care exist. Our aim was to assess the quality of care for
patients dying from cancer, as perceived by bereaved rela-
tives, within hospitals in seven European and South Ameri-
can countries.
Materials and Methods. Postbereavement survey by post,
interview, or via tablet in Argentina, Brazil, Uruguay, U.K.,
Germany, Norway, and Poland. Next of kin to cancer
patients were asked to complete the international version
of the Care Of the Dying Evaluation (i-CODE) questionnaire
6–8 weeks postbereavement. Primary outcomes were
(a) how frequently the deceased patient was treated with
dignity and respect, and (b) how well the family member
was supported in the patients’ last days of life.
Results. From 1,683 potential participants, 914 i-CODE
questionnaires were completed (response rate 54%).
Approximately 94% reported the doctors treated their fam-
ily member with dignity and respect “always” or “most of
the time”; similar responses were given about nursing staff
(94%). Additionally, 89% participants reported they were
adequately supported; this was more likely if the patient
died on a specialist palliative care unit (odds ratio, 6.3; 95%
confidence interval, 2.3–17.8). Although 87% participants
were told their relative was likely to die, only 63% were
informed about what to expect during the dying phase.
Conclusion. This is the first study assessing quality of care
for patients dying from cancer from the bereaved relatives’
perspective across several countries on two continents. Our
findings suggest many elements of good care were prac-
ticed but improvement in communication with relatives of
imminently dying patients is needed. Clinical trial informa-
tion: NCT03566732 The Oncologist ;9999:• •
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Symptom Management and Supportive Care
IMPLICATIONS FOR PRACTICE: Previous studies have shown that bereaved relatives’ views represent a valid way to assess care for
dying patients in the last days of their life. The Care Of the Dying Evaluation questionnaire is a suitable tool for quality
improvement work to help determine areas where care is perceived well and areas where care is perceived as lacking.
Health care professionals need to sustain high quality communication into the last phase of the cancer trajectory. In particu-
lar, discussions about what to expect when someone is dying and the provision of hydration in the last days of life represent
key areas for improvement.
INTRODUCTION
Cancer is the second leading cause of death worldwide and
responsible for nearly 10 million deaths in 2020 [1]. Conse-
quently, care of the dying is an important and integral part
of cancer care, and this phase deserves equal attention as
other parts of the cancer trajectory.
On the American continent, 50% of cancer deaths take
place in Latin America and the Caribbean [2]. With their
combined population of 1.4 billion, Europe and South
America account for almost 27% of the world’s cancer
deaths [2]. Reports have shown challenges and disparities
in the quality of end-of-life care both between and within
countries in these two regions [3–6]. The global inequalities
for serious health-related suffering and the need to inte-
grate palliative care into health care systems have been rec-
ognized [7]. Whereas most countries in Western Europe are
categorized as having palliative care at advanced stage of
integration into mainstream service provision, no countries
in South America have reached this level. Some countries
(e.g., Argentina and Uruguay) have palliative care at prelim-
inary stage of integration, whereas Brazil, among others, is
characterized by generalized palliative care provision, but
without integration of palliative care services into main-
stream health care provision [8].
This situation led the Network of the European Union
and the Community of Latin American and Caribbean States
on Joint Innovation and Research Activities (ERANet-LAC) to
select “Improving the quality of care and quality of life of
dying cancer patients” as the health topic for their second
Joint Call in 2016 [9]. The call specifically asked for multi-
center studies with the aim of using data from patients or
relatives to advance the international evidence-base in care
for patients dying from cancer.
In response to the ERANet-LAC call, the current study
aimed to conduct an international observational study of
bereaved relatives to patients with cancer dying in hospitals
across seven countries in Europe and South America. We
sought to assess the current quality of care, provide cross-
country comparisons, and identify areas where care needs
to be improved. In particular, clear and timely communica-
tion with patients and family members is fundamentally
important in this phase of illness [10, 11] with concerns
about hydration being especially pertinent [12]. Therefore,
within this manuscript, as well as the key outcomes (being
treated with dignity and respect; adequacy of family sup-
port), we specifically report on aspects of communication in
the last days of life.
MATERIALS AND METHODS
Study Design and Participants
This study was an international postbereavement survey by
postal questionnaire or interview after “expected” cancer
deaths in hospitals within three South American and four
European countries: Argentina, Brazil, Uruguay, Germany,
Norway, Poland, and the U.K.
The patient cohort consisted of adult patients with can-
cer who died an expected death in one of the hospitals rec-
ruited as study sites. The patient must have been admitted
to the hospital (any ward) for at least three calendar days,
with the next of kin present at least some of the time dur-
ing the patient’s last two days. The attending physician was
consulted if there was any doubt whether or not the death
was expected; if not available, any death of a patient with
cancer which did not involve cardiopulmonary resuscitation
was accepted.
“Patient with cancer” was defined as any patient with a
solid cancer or hematological malignancy, not necessarily
dying from the malignancy.
The patients’ next of kin were invited to complete the
survey and constitute the study participants. “Next of kin”
was defined as the person recorded as next of kin in the
patient’s hospital record.
Next of kin were eligible if they were ≥18 years of age
and able to provide informed consent. They were ineligible
if they were unable to complete the questionnaire due to
language abilities or reduced cognitive functioning. Eligibil-
ity was evaluated by staff on the ward where the patient
died, by research staff reviewing the medical file after the
patient’s death, and by research staff contacting next of kin
to invite them to participate in the study (Table 1).
Data Collection Tools
Screening: The following information was recorded by the
ward staff or taken from the medical record for all eligible
cases: deceased patient’s gender, age group, primary site of
cancer (predefined groups), and type of ward they died on;
length of hospital stay; whether the patient received sup-
port from a hospital specialist palliative care (SPC) team,
and/or by an individualized care plan during the dying
phase of their illness; next of kin’s gender and age group.
Ethical approval was obtained to store this information for
all eligible cases, both participants and nonparticipants, but
not to register information about ethnicity/nationality and
religious affiliation for nonparticipant cases.
International version of the Care Of the Dying Evalua-
tion (i-CODE): Data from next of kin were collected using
the i-CODE questionnaire, the international version of the
validated 42-item Care of the Dying Evaluation (CODE)
© 2021 The Authors.
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questionnaire (supplemental online File 1) [13]. CODE is a
shortened, more user-friendly version of the original instru-
ment, Evaluating Care and Health Outcomes – for the
Dying, which has been shown to be valid, reliable, and sen-
sitive in detecting unmet needs and differing perceptions of
care [14, 15]. Both questionnaires are unique as their con-
ceptual basis originates from the key components recog-
nized as best practice for “care for the dying” (last days of
life) [16]. CODE assesses both quality of patient care and
the level of family support, representing the fundamental
“pillars” of palliative care [17]. It is composed of 32 main
questions with 10 additional questions focused on demo-
graphic details. CODE includes assessment of pertinent
issues such as the provision of fluids and what to expect
when someone is dying, which are not covered within other
available tools. The two key outcomes are: “How much of
the time the patient was treated with dignity and respect”
(question 30), and “How adequately the family were
supported” (question 31).
Although there are a number of different post-
bereavement tools, a previous review identified issues with
instruments using “satisfaction” as an outcome measure
[16]. A more recent systematic review identified CODE as
an instrument, with some strong psychometric properties,
which would benefit from further development and valida-
tion [18]. Hence, pretesting survey methods helped ensure
the CODE questionnaire had good face and content validity
and was suitable for use in the seven countries [19].
Web survey of study sites: A short questionnaire
assessing hospital characteristics and the level of palliative
care provision was developed by the project team to collect
background information about the study sites. The ques-
tionnaire was completed online by the local project coordi-
nator at each participating hospital.
The survey software Corporater Surveyor (www.
corporater.com) was used to collect all data. This software
was developed in Norway specifically for collecting patient
and relative generated outcomes. One screening database
and one i-CODE database were set up for each country. The
databases were set up in English because this was the com-
mon project language and it would ease merging of the
data sets.
Procedures
Study participants were recruited by 22 hospitals in the
seven countries (Table 1). The hospitals represented a
range of different institutions and levels of palliative care
provision, and all except two (one in Germany and one in
Poland) had an SPC service that functioned as the local con-
tact for the study. The study period commenced on August
15, 2017, with the last eligible patients included on
September 15, 2018. Because of lengthy procedures for
ethical approval, the U.K. joined the study from October
1, 2017. Information about how potential study participants
were identified and approached, and the methods used for
data collection, is given in Table 1.
Screening information was registered on paper forms by
local ward staff or research staff upon identification of
potential participants. The forms were collected by mem-
bers of the local study team, who also entered the
information into the screening databases. The i-CODE ques-
tionnaire was presented to all participants 6–8 weeks after
the patient’s death. This time frame was chosen because a
previous study found no difference in terms of distress
when approaching bereaved relatives 6 weeks and 3 months
after the death [20]. Additionally, it was in keeping with the
time frame used within our pretesting study [19].
The study was originally intended as a postal survey, but
because of poorly functioning postal services, issues with
literacy, or experiences with very low response rates, differ-
ent data collection methods were selected in Poland (com-
puter-assisted personal interviewing using tablet) and the
South American countries (interview). Further details are
given in Table 1 and Figure 1. The i-CODE responses were
entered into the Corporater Surveyor database for each
country by the national study coordinators or their local
study teams. Free-text comments from within the i-CODE
questionnaire were translated into English by the national
study coordinators. Data were stored on a protected
research server.
The study was approved by relevant ethical bodies in
the participating countries (see Acknowledgments). Partici-
pants gave written informed consent. In Norway and the
U.K., participants were informed that consent was implied
when the next of kin completed and returned the
questionnaire.
Outcomes
The two primary outcomes were the participants’ (next of
kin’s) perceptions about (a) how much of the time the
patient was treated with dignity and respect in the last days
of life, by doctors and by nurses (question 30); and
(2b) whether or not the participant was adequately
supported during the same time period (question 31).
Additionally, we report on specific questions within the
i-CODE questionnaire about the communication relating to
preparedness prior to death and the provision of fluids.
Data Analysis and Statistical Methods
Data were exported from Corporater Surveyor to Excel files,
quality assured for duplicates and wrong entries, and ana-
lyzed using R version 3.5.3 and 3.6.0 [21].
For the individual response options, we present the
results as counts and percentages, both overall and strati-
fied by country. All items, including binary and ordinal
items, were scored on a 0–4 scale (with 2–5 response
options, depending on the item), where “0” indicates a low
and “4” a high quality of care [22]. For these items and
their corresponding sum scores, we report mean values,
SDs, and 95% confidence intervals (CIs). To calculate the
CIs, we used the percentile bootstrap, with 9,999 bootstrap
replications.
Question pairs with logical dependencies (questions
17 and 18, asking about the provision of fluids; and ques-
tions 24 and 25, asking about what to expect when their
family member was dying) were recoded to be internally
consistent (a “yes” on the first question implies “not appli-
cable” on the second question; supplemental online File 1).
We also investigated if there was an association
between the presence of SPC and the participants’
© 2021 The Authors.
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perceptions about (a) whether the patient was treated with
dignity and respect (by doctors and by nurses; question
30, part “a” and “b”), and (b) whether the participant was
adequately supported during the patient’s last days of life
(question 31). We did this by fitting separate mixed-effects
regression models for questions 30 (linear regression) and
31 (logistic regression). The main explanatory variables
were (a) did the patient die on a specialist palliative care
unit (PCU)? (b) Was a SPC team involved in the patient’s
care before death? and (c) was the care of the patient
supported by an individualized care plan? We also included
additional demographic variables: the patient’s age, gender,
and the country of the hospital. To adjust for any additional
hospital-level differences, we included hospital as a random
effect (random intercept). Reported p values have not been
adjusted for multiple comparisons. The p values ≤ .05 are
considered statistically significant.
Definitions: The following definitions were used for the
main exploratory variables. SPC team: interdisciplinary palli-
ative care team with consultation available in both outpa-
tient and inpatient settings, consisting of palliative care
physicians and palliative care nurses, at a minimum, and
social worker, chaplain, and/or rehabilitation specialist
(physical therapy, occupational therapy, or rehabilitation
medicine). Palliative care consultations provide comprehen-
sive baseline and ongoing assessments that include evalua-
tion of quality of life and physical, psychological, spiritual,
and social domains and prognostic disclosure [23].Specialist
PCU: hospital inpatient unit with a SPC staff team responsi-
ble for patient care. PCUs admit palliative care patients with
the most complex and difficult needs, and although the
main focus is short-term symptom management, some
patients need specialized inpatient care until death [24].
Individualized care plan: a plan of care specifically for the
dying phase, personalized to the individual and covering
their specific end-of-life care needs such as food and drink,
symptom control, psychological, social and spiritual support
[25]. One example of a framework for an individualized care
plan is the PAMPA plan used in Argentina [26].
Missing data: There were little missing data on the pri-
mary outcome variables (<5%) and on the variables
included in the regression models (<10%), so we used com-
plete case analysis for all analyses.
Sample size considerations: The study aimed for at least
100 completed i-CODE questionnaires per country, to
ensure that estimates of any country-specific percentage
value could be provided with a precision within  10 per-
centage points (95% CIs).
RESULTS
Study sites
All 22 participating hospitals answered the web survey, rep-
resenting both public and private hospitals. The number of
beds used for study recruitment ranged from 115 (Poland)
to 2,244 (Germany; Table 1). None of the South American
hospitals had an inpatient PCU, whereas 86% of the partici-
pants in Poland were recruited from PCUs.
Participants and Patients
From 1,683 potential participants who met study eligibility
criteria and were screened for participation, 914 i-CODE
questionnaires were completed and returned (response
rate 54%). Variability in response rates was seen between
countries for the postal administration (range, 34%-–8%)
and the interview-administered questionnaire (range, 58%–
95%; Fig. 1). Participants tended to be female (67%) and
the spouse or partner to the deceased patient (45%;
Table 2), although there was variability between countries
(supplemental online file 2). Almost half (49%) of the
patients died on Medical and Surgical wards (Table 2).
Participants and nonparticipants were similar in terms
of age and gender (for both participant and deceased
patient), cancer diagnosis, type of ward, involvement of a




Generally, the participants’ perception of the patient’s care
was very good. Approximately 94% (820/876) perceived
that the doctors treated their family member with dignity
and respect “always” or “most of the time” and similar
responses were given for perceptions about nursing staff
(94%, 849/902; Table 3). With 0 (never) and 4 (always) as
the minimum and maximum obtainable scores, the inter-
country variation was 3.3–4.0 (Table 3). Additionally, 89%
(788/884) of participants reported they were adequately
supported in the patient’s last days of life, with more than
80% responding positively for each individual coun-
try (Fig. 2).
Regression analyses demonstrated that the participants’
perceptions about how much of the time the patient was
treated with dignity and respect in the last days of life
(question 30) was higher if the patient died on a PCU as
compared with other wards (Table 4). For doctors, the score
difference was 0.28 (95% CI, 0.10–0.46; p = .003), and for
nurses, it was 0.17 (95% CI, 0.01–0.33; P = .04).
Whether the patient died on a PCU was also strongly
associated with participants’ perceptions about whether
they were adequately supported during the patient’s last
days of life (question 31), with an odds ratio of 6.3 (95% CI,
2.3–17.8). The unadjusted proportion of participants
responding “yes” to this question was 98% for patients who
died on a PCU and 86% for other patients.
In contrast, neither the support from a SPC team nor via
an individualized care plan was statistically significantly
associated with the primary outcomes (Table 4).
Communication
Analysis of the questions relating to communication
showed that 87% of the participants had been told their rel-
ative was likely to die soon (intercountry range, 79%–96%).
Fewer participants reported discussions, however, about
what to expect when their family member was dying (ques-
tion 24, 63%) and about the provision of fluids (question
17, 55%; Fig. 2). Answers to the subsequent questions
25 and 18 showed that, respectively, 61% and 34% of the
© 2021 The Authors.
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participants who did not have these discussions, would
have wanted them.
DISCUSSION
This study represents the first time a comparison of hospital
care has been undertaken from the bereaved relatives’ per-
spective, about the quality of care for dying patients in
Europe and South America. Overall, this international post-
bereavement survey showed quality of care for dying
patients was generally perceived as good. Participants indi-
cated that their family members had been treated with dig-
nity and respect and perceived themselves to be
adequately supported. The participants to those patients
who died in a PCU gave, on average, higher perceived qual-
ity of care scores. Participants perceived that care was lac-
king in terms of unmet information and communication
needs: in particular, regarding the provision of information
about what to expect when their family member was dying
and the provision of hydration in the last days of life.
The finding that care and support were rated more
highly when the death occurred in a PCU is in keeping with
previous studies [27–29]. Another study showed the provi-
sion of information was perceived to be better when death
occurred within a hospital PCU compared with a general
hospital ward supported by a hospital SPC team [30]. The
majority of cancer deaths, however, do not occur in special-
ized units, and within South America, none of the recruiting
hospitals had a PCU. Ways to upskill the generic hospital
health care workers are needed to improve the cultural
approach toward the dying and provide a more equitable
level of care. Initiatives involving a focus on the last days of
life have been tested for feasibility and the need for ongo-
ing training and supervision reinforced [26].
Ongoing communication between the health care team,
the patient (where able), and the family members is a vital
part of care during the dying phase [31–34]. Although there
is a current emphasis on advance care planning and involve-
ment in decision-making, this should not lead to less focus
on information about what to expect (symptoms, signs)
when someone is dying [35, 36]. Our results showed that
even though information about impending death was given
in most cases, subsequent discussions about the actual
dying process were insufficient from the bereaved relatives’
perspective. This potentially could have impact on the sub-
sequent psychological well-being of the bereaved [37–39].
In particular, the issue of hydration was recognized as
an unmet need and is consistent with previous post-
bereavement studies [40, 41]. Hydration in the last days of
life is an emotive and challenging area, with very limited
evidence about benefits and burdens [42, 43]. The lack of
discussions about this issue may reflect health care profes-
sionals’ uncertainties about how to broach the topic [44].
With training in end-of-life care often being inconsistent
and variable [45], this represents an ongoing
educational need.
The strengths of this study include the international par-
ticipation and the focus specifically on the dying phase.
Additionally, although there are several postbereavement
questionnaires assessing quality of care, the “CODE”
questionnaire is regarded as having the strongest psycho-
metric properties [18]. The “i-CODE” questionnaire was
developed and validated with target users at every step,
including the latest pretesting for the present survey [19].
Although evaluating care from the patients’ perspective is
the “gold” standard, using views from those close to them
such as their family members has recognized validity [46].
Next of kin are able to provide perceptions about the qual-
ity of care provided to their family member as well as their
own recollections about their experience. Finally, partici-
pants were recruited consecutively and many countries had
a good response rate.
The study has limitations. First, the postbereavement
survey was only performed in a limited number of hospitals
in each country. Although the South American hospitals
were generally representative for their country or region,
being both public and private hospitals, we cannot general-
ize the results to be representative of each country, espe-
cially because all the hospitals had a SPC service.
Additionally, although Poland included general hospital
wards, the majority of participants were recruited from
PCUs as dying patients within the hospital tended to be
transferred there. This may have led to bias in terms of care
being perceived more favorably than it would have been
for other hospitals within the country. Second, different
approaches to recruitment and completion of the question-
naire were used, and there was variability in the individual
country response rates. Proxy characteristics play a role in
influencing response rates [47], and variability was seen
between different countries. Both these factors could
potentially lead to response bias. The different recruitment
approaches and the criteria for “expected death” were
pragmatic decisions. We perceived that with clinician
involvement, this would help identify appropriate deceased
individuals. Postal administration would not have been fea-
sible within the South American countries.
The main implication of our study is the need for health
care professionals to sustain high quality communication
into the last phase of the cancer trajectory. This is in keep-
ing with recommendations from some of the participating
countries [48]. Family members may have no experience
with death and dying and look for guidance in an unknown
territory. Further research should address optimal ways of
meeting their needs and assess how the present results
may be transferred into clinically useful approaches. We
believe the i-CODE questionnaire can be a useful tool for
quality improvement, and in the next phase of the research,
quality improvement projects based on the bereaved rela-
tives’ identified concerns are being carried out in several of
the participating hospitals.
CONCLUSION
To our knowledge, this is the first study assessing the care
of patients dying from cancer across several countries on
two continents. Our findings suggest that many elements of
good care for dying patients were practiced. At the same
time, areas for improvement were identified, with commu-
nication by health care professionals with relatives of dying
patients being the most pertinent across the study sites.
© 2021 The Authors.
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Table 1. CODE International Survey: Information about the study sites, identification and approach of participants, and data
collection methods
Study sites (type of
hospital and wards;




Method of approach and
recruitment Data collection methods
Argentina 3 university hospitals (2
public, 1 private)
Medical, surgical, and
oncology wards, ICU (n
= 395)
Review by local study
team, using lists of
deceased patients during
the last month (provided
by key administrative
personnel or the
Department of Quality and
Patient Safety at the
hospitals)
Mostly via telephone
invitation from a study
team member, at least 6
wk after bereavement; or
verbal information was
given to next of kin at the
hospital by members of
the specialist palliative
care team.
Telephone (50%) or face-
to-face interviews (37%)
(at the hospital or in the












By the specialist palliative
care team on the wards, or




passed on information to
the local study team)
By telephone from a study




surface mail, or WhatsApp
mobile phone app.
Face-to-face interviews at
the hospital (43%) or
interviews by telephone or










PCU (n = 2,244)
By the Department of
Medical Controlling or the
Department of Quality
Assurance in cooperation
with the local study team,
when reviewing the
medical documentation 4–
6 wk after the death of a
patient





out 2 wk later by
surface mail to all who
did not actively opt out.




(94% of the respondents
answered to the first
postage, 6% to the
reminder)
Norway 3 university hospitals and
4 acute care hospitals
(all public hospitals)
Medical, surgical, and
oncology wards, PCU (n
= 423)
By the ward staff, who
immediately upon the
death of a patient
screened the case notes
according to the inclusion
criteria
Verbal information and
through a leaflet prior to
the next of kin leaving the
hospital after the patient’s
death. If missed, leaflet
was sent by surface mail.
Questionnaire pack sent
out 6–8 wk later by
surface mail to all who did
not actively opt out.




(60% of the respondents
answered to the first
postage, 40% to the
reminder)




wards, PCU (n = 115)
By ward staff (physicians
and nurses) within 3 d
after the death of a
patient. Contact
information sent to the
local study coordinator
Via telephone invitation
from a psychologist in
the local study team 4
wk postbereavement. If
the patient did not
refuse, an appointment





visited next of kin in their
homes (or a different







interviewer to enter their
answers




ICU, PCU (n = 1,425)
By staff at the hospital’s
Bereavement office within
72 hours of the death,
highlighting patients who
had cancer recorded on
their death certificate.
Local study team then
screened the case notes of
the patients highlighted to
determine eligibility
Verbal information and
through a leaflet when









Postal or online survey;
one postal reminder to
nonrespondents after 4
wk.
(78% of the respondents
answered to the first
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Table 1. (continued)
Study sites (type of
hospital and wards;




Method of approach and
recruitment Data collection methods
who did not actively opt
out.
Uruguay 2 private hospitals
Medical, surgical, and
emergency HDU wards,
ICU (n = 330)
By the nurses from the
specialist palliative care
team, who visited the
hospital wards on a
regular basis
Verbal information by a
nurse from the specialist
palliative care team. If
next of kin agreed to
receive an invitation to the




approximately 6 wk after
the death.
Telephone interviews
(about 50%) or face-to-
face interviews in next-of
kin’s home or at the
hospital. Interviews were
conducted by nurses from
the specialist palliative
care team (but always
someone not involved in
the direct care of the
patient and family in
question)
Abbreviations: HDU, high dependence unit; ICU, intensive care unit; PCU, palliative care unit
© 2021 The Authors.
The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.
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Male 527 (58) 298 (33)
Female 387 (42) 610 (67)
(Missing) 0 (0) 6 (1)
Age
18–29 3 (0) 26 (3)
30–39 13 (1) 95 (11)
40–49 39 (4) 148 (16)
50–59 117 (13) 241 (27)
60–69 244 (27) 208 (23)
70–79 290 (32) 150 (17)
80–89 179 (20) 35 (4)
90+ 29 (3) 0 (0)
(Missing) 0 (0) 11 (1)
Religious affiliationb
Christian 732 (82) 703 (78)
None 117 (13) 141 (16)
Other 47 (5) 56 (6)
(Missing) 18 (2) 14 (2)











Gastrointestinal, incl. pancreatic 321 (35)
Respiratory organs 196 (21)
Leukemia/lymphoma 100 (11)






Type of ward where the patient died
Medical or surgical ward 447 (49)
Palliative care unit 231 (25)
Oncology ward 119 (13)
Intensive care unit 69 (8)
Emergency unit 42 (5)
(Missing) 6 (1)
Specialist palliative care team involved in the patient’s care before death
(continued)
© 2021 The Authors.
The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.
www.TheOncologist.com













aMissing data presented but not included in the percentage calculations.
bRange for patients: Christian: 73% (Norway) to 92% (Brazil); none: 0% (Brazil) to 20% (Norway); other: 0% (U.K.) to 10% (Uruguay). Range for
participants: Christian: 62% (Uruguay) to 92% (Brazil); none: 0% (Brazil) to 23% (Uruguay); other: 0% (UK) to 14% (Uruguay).
c16 patients registered with two cancer types and 2 patients registered with three cancer types.
© 2021 The Authors.
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Table 3. Bereaved relatives’ perceptions about “How much of the time was your relative treated with respect and dignity in









(4), % Mean SD
95%
CI
Argentina Doctors 104 2 7 18 73 3.5 0.9 3.3–
3.7
Argentina Nurses 103 2 16 19 63 3.3 1.2 3.0–
3.5
Brazil Doctors 103 0 8 17 75 3.6 0.8 3.4–
3.7
Brazil Nurses 104 0 15 18 66 3.4 1.1 3.1–
3.6
Germany Doctors 173 1 2 10 87 3.8 0.7 3.7–
3.9
Germany Nurses 181 0 3 13 84 3.8 0.6 3.7–
3.9
Norway Doctors 182 1 9 17 73 3.5 0.9 3.4–
3.7
Norway Nurses 191 0 4 12 84 3.8 0.6 3.7–
3.9
Poland Doctors 96 0 0 4 96 4.0 0.2 3.9–
4.0








Nurses 100 3 2 6 89 3.8 0.8 3.6–
3.9
Uruguay Doctors 123 0 2 10 89 3.9 0.5 3.8–
3.9
Uruguay Nurses 124 0 1 9 90 3.9 0.4 3.8–
3.9
Total Doctors 876 1 5 13 81 3.7 0.8 3.6–
3.7
Total Nurses 902 1 5 12 82 3.7 0.8 3.6–
3.7
Abbreviations: CI, confidence interval; Resp.: number of respondents.
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Table 4. Mixed-effects multiple regression analyses for next of kin’s perception of the quality of care (n = 833–841)
Variable
Q30 doctorsa (n = 833) Q30 nursesa (n = 855) Q31b (n = 841)
Coef. (95% CI) p value Coef. (95% CI) p value OR (95% CI) p value
Intercept 3.22 (2.82–3.62) 3.57 (3.25–3.89) 2.72 (1.11–6.69)
Country (ref.: U.K.) .02 <.001 .08
Argentina 0.32 (0.19–0.83) .20 0.35 (0.74–0.03) .07 1.51 (0.69–3.27) .30
Brazil 0.43 (0.13–0.98) .12 0.22 (0.64–0.20) .29 1.45 (0.64–3.26) .37
Germany 0.54 (0.10–1.17) .09 0.12 (0.35–0.59) .60 2.78 (1.20–6.43) .02
Norway 0.23 (0.23–0.69) .29 0.12 (0.23–0.47) .49 2.35 (1.06–5.20) .04
Poland 0.47 (0.05–1.00) .07 0.09 (0.31–0.49) .64 2.16 (0.53–8.74) .28
Uruguay 0.62 (0.07–1.16) .03 0.23 (0.18–0.65) .25 4.06 (1.60–10.33) .003
Age (ref.: 18–59 years) .64 .39 .33
60–79 yr 0.05 (0.20–0.10) .50 0.07 (0.06–0.21) .30 1.12 (0.61–2.07) .71
80+ yr 0.00 (0.18–0.18) .99 0.11 (0.05–0.27) .17 0.74 (0.37–1.49) .40
Female gender 0.04 (0.07–0.15) .48 0.07 (0.04–0.17) .21 1.03 (0.65–1.64) .90
PCU 0.29 (0.09–0.49) .004 0.19 (0.02–0.36) .03 6.32 (2.25–17.76) <.001
SPC team 0.07 (0.21–0.07) .32 0.12 (0.25–0.00) .05 0.96 (0.57–1.62) .87
Individualised care plan 0.10 (0.04–0.24) .16 0.09 (0.04–0.22) .17 1.60 (0.93–2.75) .09
aLinear mixed-effects regression model. The question was “How much of the time was s/he treated with respect and dignity in the last two days
of life?,” with possible responses ranging from 0 (Never) to 4 (Always).
bLogistic mixed-effects regression model. The question was “Overall, in your opinion, were you adequately supported during his/her last two
days of life?” (yes/no).
Abbreviations: Coef., regression coefficient; CI, confidence interval, OR, odds ratio; PCU, palliative care unit; Q, question; ref., reference; SPC,
specialist palliative care
© 2021 The Authors.
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Figure 1. Comparison of interviewer versus postal questionnaire administration. *Response rate for the screened patients.
Abbreviation: i-CODE, international version of the Care Of the Dying Evaluation.
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Figure 2. Bereaved relatives’ perceptions about support and about specific aspects of communication in the last days of the
patient’s life (question 31, n = 884, question 23, n = 905; question 24, n = 904; question 17, n = 780). Mean scores with 95% con-
fidence intervals.
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